Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition
Authors
Keywords
-
Journal
CYTOTHERAPY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-28
DOI
10.1016/j.jcyt.2021.03.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy
- (2020) Patrick Innamarato et al. MOLECULAR THERAPY
- Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer
- (2020) Anders Handrup Kverneland et al. Oncotarget
- Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
- (2019) Linh T. Nguyen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Early and late hematologic toxicity following CD19 CAR-T cells
- (2019) Shalev Fried et al. BONE MARROW TRANSPLANTATION
- Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
- (2019) Graham Pawelec et al. Frontiers in Immunology
- Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients
- (2019) Estefanía Paula Juliá et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery
- (2019) Chiara Agrati et al. Frontiers in Immunology
- Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
- (2019) U Dafni et al. ANNALS OF ONCOLOGY
- Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil
- (2018) Charles Herbaux et al. BLOOD
- The Balance of Th17 versus Treg Cells in Autoimmunity
- (2018) Gap Lee INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Haematological toxicities with immunotherapy in patients with cancer: a systematic review and meta-analysis
- (2018) Fausto Petrelli et al. EUROPEAN JOURNAL OF CANCER
- Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study
- (2018) Magnus Pedersen et al. OncoImmunology
- Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives
- (2017) Ken-ichi Matsuoka INTERNATIONAL JOURNAL OF HEMATOLOGY
- Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
- (2017) Brent H. Koehn et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
- (2017) Eileen Shiuan et al. Journal for ImmunoTherapy of Cancer
- Recent advances in T-cell immunotherapy for haematological malignancies
- (2016) Rayne H. Rouce et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
- (2016) R. Andersen et al. CLINICAL CANCER RESEARCH
- Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma
- (2016) Stephanie L. Goff et al. JOURNAL OF CLINICAL ONCOLOGY
- Naive T Cell Maintenance and Function in Human Aging
- (2015) Jörg J. Goronzy et al. JOURNAL OF IMMUNOLOGY
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab
- (2015) Jon Bjoern et al. OncoImmunology
- Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review
- (2013) Gary H. Lyman et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
- (2013) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Communicating Safe Outpatient Management of Fever and Neutropenia
- (2013) Christopher R. Flowers et al. Journal of Oncology Practice
- Reconstitution of Interleukin-17–Producing T Helper Cells after Allogeneic Hematopoietic Cell Transplantation
- (2012) Felix Bahr et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Hallmarks of human “immunosenescence”: adaptation or dysregulation?
- (2012) Graham Pawelec Immunity & Ageing
- Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy
- (2011) Gustav J. Ullenhag et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
- (2010) M. E. Dudley et al. CLINICAL CANCER RESEARCH
- Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
- (2010) M. J. Besser et al. CLINICAL CANCER RESEARCH
- Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age
- (2010) E. Castermans et al. HAEMATOLOGICA
- The effect of aging on human lymphocyte subsets: comparison of males and females
- (2010) Jun Yan et al. Immunity & Ageing
- Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells
- (2009) Claudia Wrzesinski et al. JOURNAL OF IMMUNOTHERAPY
- The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of age
- (2008) Anders Wikby et al. BIOGERONTOLOGY
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started